Sodium chondroitin sulfate
Chondroitin Sulfate (Bovine / Avian Sodium Salt) · also known as Chondroitin sulfate, Chondroitin sodium, Chondroitin, CSA/CSC
Chondroitin sulfate is a large glycosaminoglycan in the cartilage matrix. Its negatively charged structure lets it hold water and keep cartilage elastic. An open-label human study measured changes in cartilage breakdown markers, but there is no direct evidence that exogenous chondroitin can repair human cartilage or inhibit degrading enzymes.
Clinical uses and human evidence
Osteoarthritis pain
Studies (2)
- Reginster 2017 · Ann Rheum Dis · RCT · n=604 — Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)
- Singh 2015 · Cochrane Database Syst Rev · Meta-analysis · n=9110 — Chondroitin for osteoarthritis
All-cause mortality risk
Heart attack, stroke and other cardiovascular events
Studies (2)
- Bhimani 2023 · J Integr Complement Med · Cohort study · n=38021 — Glucosamine and Chondroitin Use and Mortality Among Adults in the United States from 1999 to 2014
- Zappalà 2026 · Osteoarthr Cartil Open · Cohort study · n=74160 — The risk of acute thromboembolic cardiovascular events in association with use of chondroitin sulphate: A comparative, propensity score-matched cohort study using Swiss healthcare claims data
Mechanisms of action
Joint cartilage matrix glycan (GAGs/Aggrecan) repair and lubrication
The negatively charged sugar chains of chondroitin sulfate help keep the cartilage matrix hydrated. An open-label human study observed changes in the breakdown marker Coll2-1, and cell experiments showed that it lowered ADAMTS-5 expression. These results do not prove that the exogenous polysaccharide reaches human cartilage directly, or that it directly inhibits degrading enzymes.
Direct inhibition of cyclooxygenase and lipoxygenase (COX-2 / 5-LOX) activity
Experiments on cultured osteoblasts showed that chondroitin sulfate affected the expression of PGE2 and related enzymes under inflammatory stimulation. This is a change in cytokine or enzyme expression, which is not the same as directly binding and inhibiting COX-2 or 5-LOX, and target-level evidence in humans is lacking.
Safety and drug interactions
Additive bleeding risk
Structurally similar to heparin-like substances. Each of these has a mild antiplatelet or fibrinolytic effect. Alone, the effect is usually small, but when several are combined, the tendency to bleed becomes more noticeable. Stop them 1–2 weeks before surgery or a tooth extraction, and watch for gum bleeding or more bruising.
With Anticoagulants Needs attention
Reports of raised INR come mainly from combination products of glucosamine and chondroitin. People taking warfarin are advised to have one extra INR check after starting, stopping or changing the dose (warfarin only).